Effect of the synthetic cannabinoid dronabinol on central pain in patients with multiple sclerosis--secondary publication;Effekten af det syntetiske cannabinoid, dronabinol, på central smerte hos patienter med dissemineret sklerose--sekundaerpublikation.

Ugeskrift for laeger

Volumn 167, Issue 25-31, 2005, Pages 2772-2774

  Svendsen, Kristina Bacher ^a   Jensen, Troels Staehelin ^a   Bach, Flemming W ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; TETRAHYDROCANNABINOL;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; ORAL DRUG ADMINISTRATION; PAIN; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; ANALGESICS, NON-NARCOTIC; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PAIN; PAIN MEASUREMENT; TETRAHYDROCANNABINOL; TREATMENT OUTCOME;

EID: 22244450082     PISSN: None     EISSN: 16036824     Source Type: Journal    
DOI: None     Document Type: Article

References (0)